InsidersTradesSigma
Browse the detailed record of transactions filed by Marguglio David J., Director. Officer active across 1 companies, notably Adamis Pharmaceuticals Corp. In total, 3 reports have been recorded. Total volume traded: €77k. The latest transaction was filed on 18 March 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
Marguglio David J. is Senior Vice President and Chief Business Officer at Adamis Pharmaceuticals Corp. He plays a key role in business strategy and development, contributing to the company's growth.